跳至主要内容
临床试验/CTRI/2023/09/057938
CTRI/2023/09/057938尚未招募4 期

EFFICACY OF FLUTICASONE NASAL SPRAY Vs FLUTICASONE NASAL SPRAY WITH TABLET FEXOFENADINE IN CASES OF ALLERGIC RHINITIS- A RANDOMISED CONTROL TRIA

KALINGA INSTITUTE OF MEDICAL SCIENCES0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with age 18-59 years.
  • Patients who gave written informed consent.
  • Patients with TNSS >4.
  • Patients who come for regular follow up.

排除标准

  • Upper or lower respiratory tract infection with in last 2 weeks of entry visit.
  • Patients with symptoms due to structural abnormalities such as grossly deviated nasal septum, nasal polyps, tumors.
  • Previous surgeries involving the nose and paranasal sinuses.
  • Use of systemic/oral corticosteroids within 30 days of the entry visit.
  • Hypersensitivity to antihistamines or corticosteroids.
  • Pregnant women. Unwilling to give consent.

研究者

相似试验

EFFICACY OF FLUTICASONE NASAL SPRAY Vs FLUTICASONE... | 临床试验